Corpus Intelligence IC Memo — THE WOODLANDS SPECIALTY HOSPITAL 2026-04-26 09:53 UTC
IC Memo — THE WOODLANDS SPECIALTY HOSPITAL
Investment Committee Memorandum | TX | 6 beds | Grade F | EBITDA uplift $861K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THE WOODLANDS SPECIALTY HOSPITAL

CCN 670267 | MONTGOMERY, TX | 6 beds | April 26, 2026
EBITDA BridgeData Room
F
Investability

1. Target Overview & Investment Thesis

THE WOODLANDS SPECIALTY HOSPITAL is a 6-bed community hospital in MONTGOMERY, TX with $11.6M in net patient revenue and a -77.5% operating margin. The hospital serves a payer mix of 8.9% Medicare, 0.0% Medicaid, and 91.1% commercial.

Thesis: Turnaround. Our ML models identify $861K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -77.5% to -70.1% (+740bps).

Net Revenue HCRIS$11.6M
Current EBITDA COMPUTED$-9.0M
Operating Margin COMPUTED-77.5%
Occupancy HCRIS5.1%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS14.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
8
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -77.5% places it below the state median. Among 8 size-comparable peers (3-12 beds), the median margin is -44.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (3-12), prioritizing same-state peers. 8 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THE WOODLANDS SPECIALTY HOSPIT (Target)TX6$11.6M-77.5%
HERITAGE PARK SURGICAL HOSPITATX12$52.5M19.2%
MEMORIAL HERMANN KINGWOODTX10$34.1M14.5%
ALTUS HOUSTON HOSPITAL LPTX10$18.3M-45.7%
LILLIAN M. HUDSPETH MEMORIAL HTX10$9.4M-42.3%
MCCAMEY COUNTY HOSPITAL DISTRITX11$8.0M-50.0%
NORTH RUNNELS HOSPITAL DISTRICTX12$7.7M-37.2%
ST LUKES HEALTH MEMORIAL SAN ATX10$7.3M-49.3%
CAPROCK HOSPITALTX10$2.0M-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $861K (740bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$244K+210bp18mo
Cost to Collect4.5%2.5%$233K+200bp12mo
Denial Rate Reduction12.0%6.5%$232K+200bp12mo
A/R Days Reduction5200.0%3800.0%$142K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$244K
Cost to Collect
$233K
Denial Rate Reduction
$232K
A/R Days Reduction
$142K
Clean Claim Rate
$10K
Total EBITDA Uplift$861K
Current EBITDA$-9.0M
+ RCM Uplift+$861K
Pro Forma EBITDA$-8.2M
Current Margin-77.5%
Pro Forma Margin-70.1%
WC Released (1x)$447K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-13.9M$-50.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-13.9M$-60.5M0.00x-100.0%
Bull Case9.0x11.0x$-12.5M$-62.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-12.5M$-71.5M0.00x-100.0%
Bear Case11.0x10.0x$-15.3M$-50.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-15.3M$-60.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 5.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 8 hospitals with 3-12 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-49.5% / P50=-44.0% / P75=-24.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.